AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec

Go back to AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec
AbbVie (NYSE: ABBV) Delayed: 230.01 --0 (-0%)
Previous Close $230.01    52 Week High $68.12 
Open $230.01    52 Week Low $50.71 
Day High $230.01    P/E 49.89 
Day Low $230.01    EPS $4.61 
Volume 18,347